International Transplant Skin Cancer Collaborative

Directions Website

International Transplant Skin Cancer Collaborative Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from International Transplant Skin Cancer Collaborative, 555 E Wells Street, Milwaukee, WI.

The International immunosuppression & Transplant Skin Cancer Collaborative is a group of dermatologic surgeons, clinicians & researchers from multiple disciplines dedicated to advancing care & understanding of skin cancer in organ transplant recipients.

ITSCC Academic Mentorship Program (IAMP) Mentor and Mentee Applications are now open!Connect. Learn. Grow. This two-year...
10/17/2026

ITSCC Academic Mentorship Program (IAMP) Mentor and Mentee Applications are now open!

Connect. Learn. Grow. This two-year program pairs ITSCC members early in their academic careers with established senior members to build relationships and support career development.

📅 Program dates: March 2027–March 2029
Program highlights include:
• Monthly or bimonthly mentorship check-ins
• Five virtual meetings each year
• In-person participation at the ITSCC Annual Meeting (held annually before the AAD meeting) and Biennial Symposium (Fall 2028)
• Mentor support to publish manuscripts and present at national meetings
• Stipend support for an in-person experience at mentors’ institutions

Eligibility:
• Mentees: Active ITSCC members who are junior faculty or will complete all training by July 2027
• Mentors: Experienced ITSCC members currently at the level of Associate Professor or Professor or have held similar, prior institutional appointments.

Deadline: December 15: https://www.itscc.org/about-itscc/news-and-events/academic-mentorship-program

10/13/2026

Meet Amanda “Mandy” Rosenthal, MD: a double board-certified dermatologist and Mohs surgeon, ITSCC Research Grant awardee, ITSCC Academic Mentorship Program (IAMP) mentee, and all-around fabulous human being! ✨
Dr. Rosenthal shares the exciting goals she has achieved with the support of her mentor, Dr. Allison Vidimos, including leading a multi-institutional study and establishing a high-risk skin cancer clinic at Cedars-Sinai.

Interested in building your own mentorship connection? IAMP mentor and mentee applications are now open! This two-year program pairs ITSCC members early in their academic careers with established senior members to build relationships and support career development.

📅 Program dates: March 2027–March 2029
Program highlights include:
• Monthly or bimonthly mentorship check-ins
• Five virtual meetings each year
• In-person participation at the ITSCC Annual Meeting (held annually before the AAD meeting) and Biennial Symposium (Fall 2028)
• Mentor support to publish manuscripts and present at national meetings
• Stipend support for an in-person experience at mentors’ institutions

Eligibility:
• Mentees: Active ITSCC members who are junior faculty or will complete all training by July 2027
• Mentors: Experienced ITSCC members currently at the level of Associate Professor or Professor, or have held similar, prior institutional appointments. 

Deadline: December 15: https://www.itscc.org/about-itscc/news-and-events/academic-mentorship-program

Nominations are open for two At-Large positions on the ITSCC Board of Directors! Nominate yourself or another eligible m...
10/04/2026

Nominations are open for two At-Large positions on the ITSCC Board of Directors! Nominate yourself or another eligible member to help advance research and care for transplant recipients with skin cancer.

Dues-paying ITSCC members who are board-certified MD/DOs are eligible. The three-year term runs March 2027–March 2030 and includes quarterly Board meetings and required attendance at the ITSCC Annual Meeting and biennial Symposium.

Submit nominations by December 15, 2026: https://forms.gle/1UC3rEqqva64kihUA (link in bio).

Questions? Contact Kathy Uy at [email protected].

A recently published JAAD study, authored by many of our ITSCC members, highlights that Mohs micrographic surgery for cu...
09/18/2026

A recently published JAAD study, authored by many of our ITSCC members, highlights that Mohs micrographic surgery for cutaneous squamous cell carcinoma with peripheral and deep en face margin assessment (MMS/PDEMA) is associated with improved outcomes when compared to standard excision with vertical margin assessment (SEVMA) for immunosuppressed patients.

🩺 What does this mean for patients?
Immunosuppression can make cutaneous squamous cell carcinoma substantially more aggressive. These findings add to the evidence supporting margin-controlled surgery as a preferred approach in this high-risk population – both for tissue conversation, and improved oncologic outcomes.

📚 Source
Voller LM, et al. “Mohs Micrographic Surgery Leads to Improved Outcomes over Standard Excision in Immunosuppressed Patients with Cutaneous Squamous Cell Carcinoma.” J Am Acad Dermatol. 2026. doi:10.1016/j.jaad.2026.08.027.

🧠 ITSCC Quiz – Answer RevealThe correct answer is… cutaneous squamous cell carcinoma (cSCC)!Solid organ transplant recip...
08/31/2026

🧠 ITSCC Quiz – Answer Reveal

The correct answer is… cutaneous squamous cell carcinoma (cSCC)!

Solid organ transplant recipients are at substantially increased risk for skin cancer due to long-term immunosuppression. Among the major skin cancers, cSCC demonstrates the greatest increase in risk, occurring approximately 65–250 times more frequently than in the general population. In comparison, the risk is increased by approximately 10-fold for basal cell carcinoma and up to 8-fold for melanoma.

Because cSCC in transplant recipients is often more aggressive and carries a greater risk of recurrence and metastasis, prevention and early detection are essential. Regular dermatologic surveillance, diligent sun protection, patient education, and consideration of chemoprevention when appropriate can all play important roles in improving outcomes.

📚 Sources
• Pappas-Taffer L, et al. Journal of the American Academy of Dermatology. 2023.
• Chen AC, et al. New England Journal of Medicine. 2023 (ONTRANS Trial).
• O’Neill CH, et al. Journal of the American Academy of Dermatology. 2023.

When should we image cutaneous squamous cell carcinoma (cSCC)?Not every cSCC requires imaging—but for high-risk tumors, ...
08/25/2026

When should we image cutaneous squamous cell carcinoma (cSCC)?

Not every cSCC requires imaging—but for high-risk tumors, imaging can identify subclinical disease, improve surgical planning, and guide multidisciplinary management.

A new multidisciplinary Delphi Consensus provides expert recommendations on when and how to incorporate staging and surveillance imaging into the care of patients with cSCC.

🔑 Key takeaways:
• Consider baseline imaging for tumors with features suggesting increased metastatic risk, including:
▫️ Bone invasion
▫️ Large-caliber perineural invasion
▫️ Extension beyond subcutaneous fat
▫️ Tumors ≥4 cm
▫️ BWH T2b/T3 or AJCC8 T3+ disease

• Poorly differentiated tumors may also warrant imaging when additional high-risk features are present.
• CT was the preferred imaging modality for both staging and surveillance among expert panelists.
• For patients requiring surveillance imaging, a common recommendation was baseline imaging followed by imaging every 6 months for 2–3 years.

While these recommendations are based on expert consensus and should complement clinical judgment, they provide an important framework for standardizing care and identifying patients who may benefit from earlier detection of occult disease.

📚 Source
Kassamali B, Schoenfeld JD, Sethi R, et al. Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. Published online July 08, 2026. doi:10.1001/jamadermatol.2026.2163

💙 Love your skin. Protect your health.Even small amounts of cumulative UV exposure can increase skin cancer risk. Protec...
07/17/2026

💙 Love your skin. Protect your health.

Even small amounts of cumulative UV exposure can increase skin cancer risk. Protect your skin every day, all year long.

Happy World Skin Health Day! Today we celebrate the global effort to protect and treat our body’s largest organ. 🩺 For o...
07/08/2026

Happy World Skin Health Day! Today we celebrate the global effort to protect and treat our body’s largest organ. 🩺

For our transplant community, skin health is a lifelong journey of protection and partnership. Drop a 💙 to show support for skin health awareness worldwide!

Celebrating outdoors this Fourth of July? 🇺🇸 Remember that UV exposure doesn’t take a holiday. For transplant recipients...
07/04/2026

Celebrating outdoors this Fourth of July? 🇺🇸

Remember that UV exposure doesn’t take a holiday. For transplant recipients, sun protection remains one of the most important ways to reduce skin cancer risk. Stay safe, stay shaded, and enjoy the holiday weekend! ☀️

✨ ✨

ITSCC members Dr. Melodi Whitley and Dr.Jackson-Cullison hosted an incredible transplant dermatology session at the Soci...
06/29/2026

ITSCC members Dr. Melodi Whitley and Dr.
Jackson-Cullison hosted an incredible transplant dermatology session at the Society for Investigative Dermatology Annual Meeting this year in Chicago.
Proud of our ITSCC stars for supporting collaboration, education, and research dedicated to improving care for immunosuppressed and transplant patients!

Address

555 E Wells Street
Milwaukee, WI
53202

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when International Transplant Skin Cancer Collaborative posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share